PHARMACOGENETIC ASPECTS IN THE METABOLISM OF PSYCHOTROPIC-DRUGS - PHARMACOKINETIC AND CLINICAL IMPLICATIONS

被引:17
作者
SPINA, E
CAPUTI, AP
机构
[1] Institute of Pharmacology, University of Messina, Messina
关键词
D O I
10.1016/1043-6618(94)80036-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:121 / 137
页数:17
相关论文
共 104 条
[1]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[2]   HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS [J].
ALVAN, G ;
BECHTEL, P ;
ISELIUS, L ;
GUNDERTREMY, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :533-537
[3]   CLINICAL CONSEQUENCES OF POLYMORPHIC DRUG OXIDATION [J].
ALVAN, G .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1991, 5 (03) :209-228
[4]   GENETIC CONROL OF NORTIPTYLINE KINETICS IN MAN - STUDY OF RELATIVES OF PROPOSITI WITH HIGH PLASMA CONCENTRATIONS [J].
ASBERG, M ;
EVANS, DAP ;
SJOQVIST, F .
JOURNAL OF MEDICAL GENETICS, 1971, 8 (02) :129-&
[5]  
BALANTGORGIA AE, 1989, THER DRUG MONIT, V11, P415
[6]   ROLE OF OXIDATION POLYMORPHISM ON BLOOD AND URINE CONCENTRATIONS OF AMITRIPTYLINE AND ITS METABOLITES IN MAN [J].
BALANTGORGIA, AE ;
SCHULZ, P ;
DAYER, P ;
BALANT, L ;
KUBLI, A ;
GERTSCH, C ;
GARRONE, G .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 232 (03) :215-222
[7]   IMPORTANCE OF OXIDATIVE POLYMORPHISM AND LEVOMEPROMAZINE TREATMENT ON THE STEADY-STATE BLOOD-CONCENTRATIONS OF CLOMIPRAMINE AND ITS MAJOR METABOLITES [J].
BALANTGORGIA, AE ;
BALANT, LP ;
GENET, C ;
DAYER, P ;
AESCHLIMANN, JM ;
GARRONE, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) :449-455
[8]  
BALDESSARINI RJ, 1985, CHEMOTHERAPY PSYCHIA
[9]  
BERGER U, 1991, CANCER RES, V51, P239
[10]   THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE [J].
BERTILSSON, L ;
ABERGWISTEDT, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :388-390